TNFRSF11B and breast cancer: In terms of survival, a prior clinical study observed a higher risk of breast cancer-specific death in women with high (above median), relative to low, OPG levels [8], and our prior study evaluating pre-diagnosis OPG concentrations and mortality outcomes reported a higher risk of death with higher OPG [9].